Groups | Time (h) | ||||
---|---|---|---|---|---|
0 h | 0.5 h | 1 h | 1.5 h | 2 h | |
Normal rats [untreated with dimethylsulfoxide, (DMSO)] Group 1 | 82.91 ± 0.3829a | 95.60 ± 0.2651a | 108.62 ± 0.3387a | 117.67 ± 0.9812a | 138.15 ± 0.4991a |
Diabetic control (administered with Streptozotocin (STZ) Group 2 | 265.9 ± 0.9826b | 278.2 ± 0.8519b | 284.7 ± 0.2911b | 279.1 ± 0.8171b | 274.9 ± 0.3012b |
Diabetic + (EFx) (100 mg/kg body weight) Group 3 | 235.0 ± 1.086 | 225.0 ± 0.8882 | 221.0 ± 0.2465 | 203.9 ± 0.8683 | 182.4 ± 0.2997 |
Diabetic + (EFx) (200 mg/kg body weight) Group 4 | 225.2 ± 0.9767 | 214.8 ± 0.8538 | 212.4 ± 0.2989 | 198.0 ± 0.6565 | 171.6 ± 0.4256 |
Diabetic + (EFx) (300 mg/kg body weight) Group 5 | 214.2 ± 1.263 | 211.5 ± 0.6072 | 202.8 ± 0.4556 | 185.7 ± 1.784 | 142.8 ± 0.7964** |
Diabetic + (EFx) (400 mg/kg body weight) Group 6 | 203.1 ± 1.652 | 192.3 ± 0.5702 | 182.8 ± 0.3597 | 162.4 ± 0.4513* | 88.45 ± 0.7672*** |
Diabetic + glibenclamide (1 mg/kg body weight) Group 7 | 198.3 ± 0.5980 | 182.4 ± 0.5737 | 170.9 ± 0.3304 | 141.7 ± 0.5050** | 82.80 ± 0.5378*** |